Skip to main content
Mastering 21 CFR Part 11; Electronic Records and Signatures in Pharmaceutical and Biotech Industries

Mastering 21 CFR Part 11; Electronic Records and Signatures in Pharmaceutical and Biotech Industries

USD211.51
When you get access:
Course access is prepared after purchase and delivered via email
How you learn:
Self-paced • Lifetime updates
Your guarantee:
30-day money-back guarantee — no questions asked
Who trusts this:
Trusted by professionals in 160+ countries
Toolkit Included:
Includes a practical, ready-to-use toolkit with implementation templates, worksheets, checklists, and decision-support materials so you can apply what you learn immediately - no additional setup required.
Adding to cart… The item has been added

Mastering 21 CFR Part 11: Electronic Records and Signatures in Pharmaceutical and Biotech Industries

Mastering 21 CFR Part 11: Electronic Records and Signatures in Pharmaceutical and Biotech Industries

This comprehensive course is designed to provide participants with a thorough understanding of the regulations and guidelines for electronic records and signatures in the pharmaceutical and biotech industries. Participants will receive a certificate upon completion issued by The Art of Service.

This course is:

  • Interactive and engaging
  • Comprehensive and personalized
  • Up-to-date and practical
  • Based on real-world applications
  • High-quality content
  • Taught by expert instructors
  • Covers certification requirements
  • Flexible learning
  • User-friendly and mobile-accessible
  • Community-driven
  • Provides actionable insights
  • Includes hands-on projects
  • Bite-sized lessons
  • Lifetime access
  • Gamification and progress tracking


Chapter 1: Introduction to 21 CFR Part 11

1.1 Overview of 21 CFR Part 11

This topic provides an introduction to the regulations and guidelines for electronic records and signatures in the pharmaceutical and biotech industries.

1.2 History and Evolution of 21 CFR Part 11

This topic covers the history and evolution of 21 CFR Part 11, including key milestones and updates.

1.3 Scope and Applicability of 21 CFR Part 11

This topic discusses the scope and applicability of 21 CFR Part 11, including the types of industries and organizations that are subject to the regulations.



Chapter 2: Electronic Records

2.1 Definition and Requirements for Electronic Records

This topic provides a detailed overview of the definition and requirements for electronic records, including the types of records that are subject to the regulations.

2.2 Controls for Electronic Records

This topic covers the controls that are required for electronic records, including access controls, audit trails, and electronic signatures.

2.3 Validation of Electronic Records

This topic discusses the requirements for validating electronic records, including the use of validation protocols and testing.



Chapter 3: Electronic Signatures

3.1 Definition and Requirements for Electronic Signatures

This topic provides a detailed overview of the definition and requirements for electronic signatures, including the types of signatures that are subject to the regulations.

3.2 Controls for Electronic Signatures

This topic covers the controls that are required for electronic signatures, including identity verification, authentication, and authorization.

3.3 Validation of Electronic Signatures

This topic discusses the requirements for validating electronic signatures, including the use of validation protocols and testing.



Chapter 4: Implementation and Compliance

4.1 Implementation of 21 CFR Part 11

This topic provides guidance on implementing 21 CFR Part 11, including the development of policies, procedures, and training programs.

4.2 Compliance with 21 CFR Part 11

This topic discusses the requirements for compliance with 21 CFR Part 11, including the use of audits, inspections, and enforcement actions.

4.3 Best Practices for 21 CFR Part 11 Compliance

This topic provides best practices for complying with 21 CFR Part 11, including the use of risk-based approaches and continuous monitoring.



Chapter 5: Audits and Inspections

5.1 Types of Audits and Inspections

This topic provides an overview of the types of audits and inspections that are used to enforce compliance with 21 CFR Part 11.

5.2 Preparation for Audits and Inspections

This topic discusses the steps that organizations can take to prepare for audits and inspections, including the development of audit plans and procedures.

5.3 Conducting Audits and Inspections

This topic provides guidance on conducting audits and inspections, including the use of audit checklists and inspection protocols.



Chapter 6: Enforcement Actions

6.1 Types of Enforcement Actions

This topic provides an overview of the types of enforcement actions that can be taken against organizations that fail to comply with 21 CFR Part 11.

6.2 Procedures for Enforcement Actions

This topic discusses the procedures that are used to initiate and conduct enforcement actions, including the use of warning letters and consent decrees.

6.3 Consequences of Enforcement Actions

This topic provides guidance on the consequences of enforcement actions, including the use of fines, penalties, and other sanctions.



Chapter 7: International Regulations and Standards

7.1 Overview of International Regulations and Standards

This topic provides an overview of the international regulations and standards that apply to electronic records and signatures in the pharmaceutical and biotech industries.

7.2 EU Annex 11 and Computerized Systems

This topic discusses the requirements of EU Annex 11 and the use of computerized systems in the pharmaceutical and biotech industries.

7.3 ICH E6 and Good Clinical Practice

This topic provides guidance on the requirements of ICH E6 and the use of good clinical practice in the pharmaceutical and biotech industries.



Chapter 8: Risk Management and Quality Assurance

8.1 Overview of Risk Management and Quality Assurance

This topic provides an overview of the principles of risk management and quality assurance in the pharmaceutical and biotech industries.

8.2 Risk-Based Approach to Compliance

This topic discusses the use of a risk-based approach to compliance with 21 CFR Part 11 and other regulations.

!